Imagine a future where you can eat out with fewer worries
With your help we can get closer to this goal.
Contribute to research on a study medication for celiac disease with minimal compromises to your life - no biopsies, no injections.
The Solutions for Celiac Study
This NIH-funded clinical research study is evaluating a drink-based study medication, latiglutenase, and its ability to relieve common symptoms suffered by celiac disease patients typically experienced after accidental gluten exposure.
The Solutions for Celiac Study has been designed to be as non-intrusive on your life as possible:
Latiglutenase is taken as a drink with meals
No mandatory endoscopy with biopsy
No treatment injections
Plus, all participants will receive the active study medication at some point during the trial.